advanced search  
Updated Jul. 30, 2010
 
 
 
 
SPECIAL EDITION / EDUCATIONAL REVIEWS

Pharmacy Practice News publishes educational reviews in its monthly issues as well as in its annual Special Edition, published in the fall. The most up-to-date reviews can be accessed below.

Assessment Tools and Guidelines: Parenteral Nutrition Therapy

Malnutrition is associated with an increased frequency of treatment complications and length of stay in the intensive care unit (ICU) and hospital, as well as increased costs of medical care. Patients at high risk for malnutrition should be identified and evaluated for specialized nutrition support (SNS).
JULY, 2010

Updates in the Diagnosis and Treatment of Mycosis Fungoides and Sézary Syndrome

MF is highly symptomatic and progressive, with poor prognosis at later stages. When MF is grouped by stage, patients with patch-plaque disease (stages IA, IB, and IIA) have a survival of more than 12 years and those with tumors or erythroderma (stages IIB/III) have a median survival of approximately 4 years; however, those with stage IV, which includes patients with lymph node or visceral involvement, have a median survival of less than 3 years. Similarly, patients with SS have a median survival of less than 3 years.
JUNE, 2010

Chemotherapy-Induced Nausea and Vomiting
Guideline Summary and Clinical Challenges

Chemotherapy-induced nausea and vomiting (CINV) can significantly impact patient care and quality of life (QoL), resulting in potential complications of electrolyte disturbances, decreased functional ability, weight loss, anorexia, esophageal tears, and treatment noncompliance.
MAY, 2010

Management of Epidermal Growth Factor Receptor Inhibitor-Induced Dermatologic Toxicity

The epidermal growth factor receptor (EGFR) is 1 of 4 types of human epidermal receptors that are found primarily on cells of epithelial origin and have a vital role in cellular growth, proliferation, and migration.1-3 Abnormal activity at the EGFR receptor has been implicated in many types of solid tumors, including colorectal, non-small cell lung, head and neck, and pancreatic cancers.
APRIL, 2010

Guidelines for the Prevention of Medication Errors

The prevention of medication errors is an essential requirement for pharmaceutical care and must be a core mission of every pharmacy. For medication error prevention efforts to be effective, they must become a priority.
APRIL, 2010

Safe Handling Of Hazardous Drugs: Reviewing Standards for Worker Protection

As a new generation of health care workers joins those already engaged in patient care, it is essential that they understand the occupational risks associated with the handling of hazardous drugs. Luci Power, MS, RPh, and Martha Polovich, MN, RN, AOCN, offer the latest updates to safe handling guidelines, and offer several strategies for reducing the risks of occupational exposure.
MARCH, 2010

Antifungal Prophylaxis in High-Risk Oncology Patients

Invasive fungal infections are a cause of considerable morbidity and mortality in patients with cancer. However, difficulty in establishing the diagnosis often results in delayed antifungal therapy, which adversely impacts survival. Prevention of invasive fungal infections is thus an appealing target for clinical and research efforts.
FEBRUARY, 2010

The Bone Continuum of Cancer: Early to Advanced Stage Disease

It is estimated that nearly 1.5 million people will be diagnosed with cancer in the United States in 2009. Survival rates of many cancers are improving, leading to an emerging population of individuals living with cancer.
FEBRUARY, 2010

[1[2[3[4[5[6

Acrobat Reader (version 4.0 or higher recommended) is required to view Pharmacy Practice News Special Edition. If you do not have Acrobat Reader, you can download it from Adobe's Web site.

McMahon Publishing also offers seven compendia of clinical educational reviews, called Special Editions, which are published annually. Please visit them by clicking the logos below.
 




Making ADCs Part of the Medication Safety Solution 1
Tramadol Labeling Changed To Include Overdose, Suicide Warning 1
Our Role in Expanding Residency Programs 2
They Didn’t Come Home 2
Treating The Patient With Metastatic Non–Smallcell Lung Cancer 1
OPINION
Our Role in Expanding Residency Programs...  [7/2010]
REMS for Opioids: A Review and Critique ...  [4/2010]
Causes and Remedies for the ‘Miserable’ Workplace ...  [4/2010]
more 
CLINICAL
Investigational Agent Stops Potentially Fatal 5-FU...  [7/2010]
Targeting Peri-op Blood Pressure Pays Off...  [6/2010]
Alvimopan Helps Reduce Length of Stay, Cost of Car...  [6/2010]
more 
OPERATIONS & MANAGEMENT
Surgicenters Often Flub Infection Control Pro...  [7/2010] (new)
Pharmacists Help Crash Carts Stay on Track...  [7/2010] (new)
The Ochsner-Aussie Connection...  [7/2010]
more 
POLICY
IOM Report Predicts Troubled Future for Cancer Res...  [6/2010]
AMA Seeks Limits to Pharmacists’ Scope of Practice...  [5/2010]
Study Calls for Some Vitamins To Be Regulated as O...  [5/2010]
more 
TECHNOLOGY
Does Telepharmacy Result in Better Care?...  [7/2010] (new)
Making ADCs Part of the Medication Safety Sol...  [7/2010] (new)
Unchaining Nurses From Drug Cabinets...  [7/2010] (new)
more 
HEM/ONC PHARMACY IN FOCUS
More Cryotherapy Urged for Preventing Oral Mu...  [7/2010] (new)
Ipilimumab Improves Survival In Advanced Mela...  [7/2010] (new)
New Standard of Care Proposed for Follicular ...  [7/2010] (new)
more 
PEOPLE IN PHARMACY
In Afghanistan, Reserve Pharmacist Answers Call To...  [2/2010]
Parents Are the Key to Keeping Kids Prescription...  [11/2009]
First Pharmacist To Lead SCCM Says Team Approach I...  [11/2009]
more 

 
 
home  |  about us  |  advertise  |  contact  |  publications
 


Copyright © 2004 - 2010 McMahon Publishing unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.